Fast Market Research recommends "Les Laboratoires Servier SAS - Product Pipeline Review - 2013" from Global Markets Direct, now available

Boston, MA -- (SBWire) -- 08/30/2013 --Global Markets Direct's pharmaceuticals report, "Les Laboratoires Servier SAS - Product Pipeline Review - 2013" provides data on the Les Laboratoires Servier SAS's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Les Laboratoires Servier SAS's corporate website, SEC filings, investor presentations and featured press releases, both from Les Laboratoires Servier SAS and industry-specific third party sources, put together by Global Markets Direct's team.

View Full Report Details and Table of Contents

Scope

- Les Laboratoires Servier SAS - Brief Les Laboratoires Servier SAS overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Les Laboratoires Servier SAS human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Les Laboratoires Servier SAS with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Les Laboratoires Servier SAS's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to Get This Report

- Evaluate Les Laboratoires Servier SAS's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Les Laboratoires Servier SAS in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Les Laboratoires Servier SAS's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Les Laboratoires Servier SAS.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Les Laboratoires Servier SAS and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Les Laboratoires Servier SAS - Product Pipeline Review - 2012
- Les Laboratoires ServierSAS - Strategic SWOT Analysis Review
- XOMA Corporation - Product Pipeline Review - 2013
- Laboratoires Pierre Fabre SA - Product Pipeline Review - 2013
- Chronic Heart Failure - Pipeline Review, H2 2013
- Laboratoires Thea S.A. - Product Pipeline Review - 2013
- Les Laboratoires ServierSAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- Ono Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013
- Vernalis plc - Product Pipeline Review - 2012
- Hypertension - Pipeline Review, H1 2013